Tenzing Acquisition Corp.(NasdaqCM:TZAC) dropped from NASDAQ Composite Index	14/20/14	CI
Reviva Pharmaceuticals, Inc. completed the acquisition of Tenzing Acquisition Corp. in a reverse merger transaction.	14/20/14	CI
Tenzing Acquisition Corp. announced that it has received $0.2 million in funding from Tenzing LLC	12/20/12	CI
Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer	05/20/05	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Second Quarter Ended August 31, 2020	15/20/15	CI
Tenzing Acquisition Corp. announced that it has received $0.35 million in funding from Tenzing LLC	24/20/24	CI
Tenzing Acquisition Corp. announced that it has received $0.125 million in funding from Tenzing LLC	18/20/18	CI
Tenzing Acquisition Corp. announced that it has received $0.175 million in funding from Tenzing LLC	24/20/24	CI
Reviva Pharmaceuticals, Inc. entered into a definitive agreement to acquire Tenzing Acquisition Corp. for $64 million in a reverse merger transaction.	21/20/21	CI
Tenzing Acquisition Corp. Reports Earnings Results for the First Quarter Ended May 31, 2020	08/20/08	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Full Year Ended February 29, 2020	04/20/04	CI
Tenzing Acquisition Corp. announced that it has received $0.75 million in funding from Tenzing LLC	10/20/10	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Third Quarter Ended November 30, 2019	11/20/11	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Second Quarter Ended August 31, 2019	09/19/09	CI
Tenzing Acquisition Corp. Reports Earnings Results for the First Quarter Ended May 31, 2019	04/19/04	CI

More news

Press releases Tenzing Acquisition Corp.

Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference	12/21/12	GL
REVIVA PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K/A)	21/21/21	AQ
REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/21/15	AQ
REVIVA PHARMACEUTICALS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, (form 8-K)	19/20/19	AQ
Tenzing Acquisition Corp. : and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination	21/20/21	PR

More press releases

Tenzing Acquisition Corp is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of similar businesses. The Company's search is not limited to any particular industry or geographic region for purposes of consummating an initial business combination. The Company is primarily focused on companies that operate in India.

Sector

More about the company

Tenzing Acquisition Corp. Share Price Nasdaq

Equities

TZACU

VGG8708A1241

Chart Tenzing Acquisition Corp.

Latest news about Tenzing Acquisition Corp.

Press releases Tenzing Acquisition Corp.

Company Profile